Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2370.88 (Glytoucan)

Id:7571b3ca-07dc-5345-b537-1803a530111d

Glytoucan:G85652RK

Results found

Linked to

	Label	Description
	2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G85652RK-GLYCOSEQ00195713 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G22944QW-GLYCOSEQ00045255 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000162 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 has motif Blood group H (type 2) - Lewis y Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G30627OI-GLYCOSEQ00127160 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G66689PB-GLYCOSEQ00163401 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G30627OI-GLYCOSEQ00127159 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000158 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000149 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G70333IQ-GLYCOSEQ00138355 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G85652RK-GLYCOSEQ00195713 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G22944QW-GLYCOSEQ00045255 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000162 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 has motif Blood group H (type 2) - Lewis y

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G30627OI-GLYCOSEQ00127160 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G66689PB-GLYCOSEQ00163401 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G30627OI-GLYCOSEQ00127159 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000158 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000149 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2370.88 has glycosequence GLYGEN.GLYCOSEQUENCE:G70333IQ-GLYCOSEQ00138355 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.